Singapore markets closed

CStone Pharmaceuticals (2616.HK)

HKSE - HKSE Delayed price. Currency in HKD
Add to watchlist
1.100+0.010 (+0.92%)
At close: 04:08PM HKT
Show:
Balance sheet
Cash flow
Annual

Income statement

Currency in CNY. All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
463,842
463,842
481,363
243,718
1,038,832
Cost of revenue
159,547
159,547
202,985
106,832
241,421
Gross profit
304,295
304,295
278,378
136,886
797,411
Operating expenses
Research development
527,799
527,799
614,162
1,304,945
1,404,684
Selling general and administrative
248,065
248,065
390,476
472,992
228,882
Total operating expenses
884,140
884,140
1,181,475
1,930,359
1,861,832
Operating income or loss
-579,845
-579,845
-903,097
-1,793,473
-1,064,421
Interest expense
11,819
11,819
8,477
2,242
1,320
Income before tax
-367,234
-367,234
-902,678
-1,920,100
-1,220,999
Income from continuing operations
-367,234
-367,234
-902,678
-1,920,100
-1,220,999
Net income
-367,234
-367,234
-902,678
-1,920,100
-1,220,999
Net income available to common shareholders
-367,234
-367,234
-902,678
-1,920,100
-1,220,999
Basic EPS
-0.77
-0.29
-0.77
-1.65
-1.17
Diluted EPS
-0.77
-0.29
-0.77
-1.65
-1.17
Basic average shares
1,172,839
1,263,073
1,172,839
1,165,209
1,046,032
Diluted average shares
1,172,839
1,263,073
1,172,839
1,165,209
1,046,032